Skip to content
Disclosery

EXANE DERIVATIVES: RHI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on RHI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,463 RHI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,463 shares
    Change vs previous 13F +1,082 shares

    0.11% of the 13F portfolio, value $184,416.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,381 shares
    Change vs previous 13F +1,005 shares

    0.04% of the 13F portfolio, value $157,673.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 376 shares
    Change vs previous 13F -372 shares

    0.01% of the 13F portfolio, value $41,930.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 748 shares
    Change vs previous 13F -293 shares

    0.02% of the 13F portfolio, value $75,044.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,041 shares
    Change vs previous 13F +3 shares

    0.02% of the 13F portfolio, value $90,471.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,038 shares
    Change vs previous 13F -310 shares

    0.02% of the 13F portfolio, value $81,033.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,348 shares
    Change vs previous 13F +1,196 shares

    0.03% of the 13F portfolio, value $84,219.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 152 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $8,046.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).